Clinical Trial Update: Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing etoposide/cisplatin with radiotherapy versus paclitaxel/carboplatin with radiotherapy for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Non-Small Cell Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED